Top Markets
#1 Black Phoenix Black Phoenix +199.86%
#2 Islamic Coin Islamic Coin +158.05%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.11%
#5 Akedo Akedo +36.87%
#6 BasedHype BasedHype +32.48%
#7 Acurast Acurast +26.69%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.07%
#9 Cryptopia Cryptopia +21.67%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +17.49%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
Kedudukan dalam Saham #41346
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Harga Saham
$0.00002
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$25.40K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-80.00%
Negara
US
Perdagangan Viropro Inc. (VPRO)

Kategori

Healthcare
Hasil untuk Viropro Inc. (VPRO)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Viropro Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Viropro Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE